Diamedica Therapeutics Inc (DMAC)
SG&A Expense Growth
28.32%
Fiscal year · Period ending:
DMAC SG&A Expense Growth
Latest reported28.32%period ending
Latest reported28.32%period ending
DMAC FY SG&A Growth (YoY) (0.00% → 28.32%)
Latest values, visible window
High-resolution chart · PNG
DMAC sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 28.3185% | |
| -6.5343% | |
| 32.3759% | |
| 26.2446% | |
| 8.6115% | |
| 21.6897% | |
| 34.8302% | |
| 108.6062% | |
| 82.8576% | |
| 69.6086% | |
| -62.2475% | |
| -55.8322% | |
| 0.2666% | |
| 21.7974% | |
| 60.4755% | |
| 28.9676% | |
| 62.4054% | |
| -55.3379% | |
| 619.9223% | |
| 8.2073% | |
| 5.2538% | |
| 0% |